Invokana Amputation Lawyer Discusses Clinical Trials and FDA Warnings

On May 16, 2017, the U.S. Food and Drug Administration (FDA) posted a safety alert regarding amputation risks associated with the diabetes medication Canagliflozin (Invokana, Invokamet XR and Invokamet). An Invokana Amputation Lawyer at the F&A Injury Law Firm in New York, NY explains that this FDA alert included a “black box warning,” which the FDA says is “designed to call attention to serious or life-threatening risks.” What is Invokana (Canagliflozin)? Invokana is a single-ingredient prescription medication that, along with exercise and a special diet, lowers blood sugar in adults diagnosed with Type II diabetes. Invokana is in a group of prescription drugs commonly referred to...

Continue reading